Company intelligence / Profile preview

Indian Immunologicals Limited

Hyderabad, Telangana, Indianddb.coop ↗

Ownership: Private
Development stage: Commercial

Overview

IIL is a major supplier of vaccines to India's Universal Immunization Programme and exports to over 50 countries. It is the largest producer of anti-rabies vaccines in the world.

Therapeutic areas: Infectious Diseases
Modalities: VaccinesBiologicals
Industry: Biotech

Drug pipeline

22 assets

anti-rabies monoclonal antibodies

Preclinical

21 more assets in the full pipeline.

Request access →

Partnerships

Polyvac Institute (Vietnam)Griffith University (Australia)

Beyond the preview

Go deeper on Indian Immunologicals Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indian Immunologicals Limited.

Explore the full profile